Brick & Kyle, Associates Amgen Inc Transaction History

Brick & Kyle, Associates

$233 Million
Q3 2024

A detailed history of Brick & Kyle, Associates transactions in Amgen Inc stock. As of the latest transaction made, Brick & Kyle, Associates holds 15,324 shares of AMGN stock, worth $4.03 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

15,324

Previous 15,516 1.24%

Holding current value

$4.03 Million

Previous $4.85 Million 1.59%

% of portfolio

2.11%

Previous 2.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $59,400 - $64,776	-192 Reduced 1.24%	15,324 $4.93 Million
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $163,693 - $198,930	623 Added 4.18%	15,516 $4.85 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $741,812 - $895,461	2,759 Added 22.74%	14,893 $4.09 Million
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $2,812 - $3,173	-11 Reduced 0.09%	12,134 $3.5 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $2,186 - $2,714	10 Added 0.08%	12,145 $3.26 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $7,499 - $8,867	35 Added 0.29%	12,135 $2.74 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $70,446 - $85,862	312 Added 2.65%	12,100 $2.93 Million
Q4 2022 Feb 16, 2023	SELL	$229.03 - $291.01 $13,283 - $16,878	-58 Reduced 0.49%	11,788 $3.1 Million
Q3 2022 Nov 16, 2022	BUY	$224.46 - $253.15 $26,486 - $29,871	118 Added 1.01%	11,846 $2.68 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $7,152 - $7,958	-31 Reduced 0.26%	11,728 $2.85 Million
Q1 2022 May 23, 2022	BUY	$219.27 - $242.57 $15,129 - $16,737	69 Added 0.59%	11,759 $2.84 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $12,728 - $14,566	64 Added 0.55%	11,690 $2.63 Million
Q3 2021 Nov 18, 2021	BUY	$212.27 - $248.7 $131,819 - $154,442	621 Added 5.64%	11,626 $2.5 Million
Q2 2021 Aug 18, 2021	SELL	$233.58 - $259.14 $4,438 - $4,923	-19 Reduced 0.17%	11,005 $2.67 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $1.75 Million - $2.04 Million	7,870 Added 249.52%	11,024 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $345,558 - $411,498	1,597 Added 102.57%	3,154 $722,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $1,173 - $1,304	5 Added 0.32%	1,557 $393,000
Q2 2020 Jul 30, 2020	BUY	$197.81 - $242.74 $1,186 - $1,456	6 Added 0.39%	1,552 $362,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $18,770 - $24,895	-103 Reduced 6.25%	1,546 $313,000
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $946 - $1,216	5 Added 0.3%	1,649 $397,000
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $17,585 - $21,070	101 Added 6.55%	1,644 $337,000
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $38,674 - $45,335	232 Added 17.7%	1,543 $0
Q1 2019 Jun 14, 2019	BUY	$180.87 - $203.88 $237,120 - $267,286	1,311 New	1,311 $0
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $182,293 - $203,677	-1,080 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $180,673 - $206,280	1,080	1,080 $201,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brick & Kyle, Associates, based on Form 13F filings with the SEC.

News

Stay updated on Brick & Kyle, Associates with notifications on news.

Account

Brick & Kyle, Associates Amgen Inc Transaction History